Browsing Tag
Activin E
2 posts
Ribo enters obesity RNAi race as RBD3133 moves toward first human study in Europe
Suzhou Ribo Life Science has filed for a European Phase I trial of RBD3133, taking its first obesity candidate toward human testing as multiple RNAi developers pursue INHBE as a potential fat-selective alternative or complement to incretin therapies.
Wave Life Sciences unveils early WVE-007 obesity trial results showing fat reduction without muscle loss
Discover how Wave Life Sciences’ WVE-007 delivered fat loss without muscle loss in its Phase 1 obesity trial and what it means for the obesity drug market.